Search

Clinical Articles / BY: Rebecca Warburton, MD, FRCSC March 2018
... all patients with invasive breast cancer. Axillary lymph node dissection (ALND) has now been replaced by sentinel lymph node biopsy (SLNB) for most patients with clinically ... to reduce regional recurrence and improve survival.[ 32 ] For women with positive results on SLNB, radiotherapy ...
Clinical Articles / BY: Connie G. Chiu, MD, FRCSC March 2018
... The estimated risk for patients undergoing axillary lymph node dissection (ALND) is 20%, compared with 5% for sentinel lymph node biopsy (SLNB).[ 1 ] However, a more clinically ... 25% and 60% of patients and has been variably defined.[ 32 ] As the surgical management of breast cancer has changed ...
Clinical Articles / BY: Christine E. Simmons, MD, MSc, FRCPC March 2018
... largely accepted as the standard of care in patients with node-positive or high-risk node-negative breast cancer.[ 3 ] Currently, guidelines ... median time from completion of chemotherapy to surgery is 32 days. Again, this has improved since the audit and ...